Thursday 22 April 2021
Home      All news      Contact us      RSS     
Tufts - 2 month ago

FDA Approves a Third COVID-19 Vaccine

Cummings School veterinary pathologist aided research behind new single-dose vaccine from Johnson JohnsonOn Feb. 27 the U.S. Food and Drug Administration approved a new single-dose vaccine from Johnson Johnson for emergency use to fight the COVID-19 pandemic. The new vaccine from Johnson Johnson was shown to be 72 percent effective in the United States and 66 percent effective globally in preventing any symptomatic COVID-19 disease in a multinational study. The vaccine was 85 percent effective at preventing severe complications from the no one who received the vaccine in the studies was hospitalized or died due to COVD-19.


Latest News
Hashtags:   

Approves

 | 

Third

 | 

COVID

 | 

Vaccine

 | 

Sources